PMID: 7931819Jan 1, 1994Paper

Serum pseudocholinesterase and very-low-density lipoprotein metabolism

Journal of Clinical Laboratory Analysis
K M Kutty, R H Payne


Serum pseudocholinesterase (PChE) was discovered in 1932. Since this protein mimics many of the catalytic properties of acetylcholinesterase, it has traditionally been referred to as PChE, even though its true biological function is unknown. Serum PChE is synthesized in the liver and secreted into the circulation as a sialated glycoprotein. Although no convincing evidence of biological function exists, a significant number of obese and diabetic patients have elevated levels of PChE. The same phenomenon is found in experimental animal models of obesity, diabetes and hyperlipoproteinemia. Streptozotocin-induced diabetic mice showed increased serum PChE activity concomitant with increased serum triacylglycerol and PChE activity declined with treatment. Iso-OMPA, a nontoxic inhibitor of serum PChE, reduced serum and liver triacylglycerols and serum VLDL in streptozotocin-induced rodent diabetes. These findings suggest that PChE may have a role in VLDL metabolism.


Feb 22, 1975·Clinica Chimica Acta; International Journal of Clinical Chemistry·M CucuianuS Hărăgus
Apr 15, 1977·Experientia·K M KuttyD Murphy
Apr 3, 1978·Clinica Chimica Acta; International Journal of Clinical Chemistry·M I ChuR Redheendran
Feb 1, 1990·Metabolism: Clinical and Experimental·G L WarwickJ Shepherd
Oct 1, 1988·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·O Lockridge
Jan 1, 1986·Journal of the American College of Nutrition·K T KeanR Jain
May 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·F YangB H Bowman
Dec 1, 1980·Clinical Biochemistry·K M Kutty
Jan 1, 1981·Clinica Chimica Acta; International Journal of Clinical Chemistry·K M KuttyK Kean
Dec 1, 1952·British Journal of Pharmacology and Chemotherapy·C J EARL, R H S THOMPSON
Jun 1, 1953·The American Journal of Medicine·L J VORHAUS, R M KARK
Sep 7, 1963·Nature·J W CLITHEROWN J HARPER
Jan 1, 1932·The Biochemical Journal·E StedmanL H Easson

❮ Previous
Next ❯


Jan 16, 2014·Indian Journal of Clinical Biochemistry : IJCB·Tanasorn TunsaringkarnAnusorn Rungsiyothin
May 24, 2005·Clinical Biochemistry·Edward W RandellGuang Sun
Nov 14, 2006·Lipids in Health and Disease·Gumpeny Ramachandra SridharCh Divakar
Jan 30, 2014·International Journal of Environmental Research and Public Health·Yutaka AokiPaul T Strickland
Jul 7, 2007·Critical Reviews in Toxicology·T WangH M Mehendale
Apr 2, 2005·Current Medical Research and Opinion·Annie H ShinnTimothy J Smith
Mar 16, 2011·Clinical Biochemistry·Marina StojanovMilica Prostran
Aug 28, 2010·Medical Hypotheses·Gumpeny R SridharThota Hanuman
Nov 6, 2010·Clinical Endocrinology·Matthew Blatnik, Catherine I Soderstrom
Sep 8, 2012·Journal of Cachexia, Sarcopenia and Muscle·Lidia SantarpiaFabrizio Pasanisi
May 3, 2008·Chemico-biological Interactions·Bin LiOksana Lockridge
Sep 1, 1995·Medical Hypotheses·K MadhavankuttyW Andrews
Jun 29, 2004·Life Sciences·János KálmánZoltán Janka
Jun 18, 2016·Toxicology·Iris MangasTanos Celmar Costa França
Oct 20, 2005·Diabetes Research and Clinical Practice·Gilberto Inácio LunkesJamile Fabbrin Gonçalves
Oct 9, 2001·Luminescence : the Journal of Biological and Chemical Luminescence·B YavoA Campa
Nov 4, 2005·Plastic and Reconstructive Surgery·Selahattin OzmenKenan Atabay
Jul 8, 2011·European Journal of Anaesthesiology·Jaideep J PanditJason Arora
Apr 20, 2014·Journal of Cardiovascular Medicine·Natalia G VallianouDemosthenes B Panagiotakos
Feb 19, 2005·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Trajan Balkanov, Slavko Konstantinović
Jul 11, 2020·Environmental Science and Pollution Research International·Iris Betzaida Molina-PintorBriscia Socorro Barrón-Vivanco
Mar 26, 2020·International Immunopharmacology·Janine SpiekerPaul G Layer

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.